How effective has the EU FMD been and how secure is the supply chain now?
TORONTO (PRWEB) April 13, 2020
Join Guillaume Frapsauce, Account Director, OPTEL GROUP, Scott Pugh, Principal, Jennason, LLC and Grant Courtney, Principal Consultant, Be4ward in a live webinar on Wednesday, April 29, 2020 at 9am EDT (2pm BST/UK).
It’s been one year since the European Union (EU) adopted the Falsified Medicines Directive (FMD) as a means of combatting counterfeiting in the pharmaceutical industry. How effective has the EU FMD been and how secure is the supply chain now?
In this webinar, OPTEL and Be4ward who are both traceability experts weigh in on the issues that still need to be addressed, including the EU FMD’s bookend approach that creates a race between authentic and counterfeit medicines in reaching the patient first.
The solution can be found in aggregation and multilayer protection such as serialization, tamper evidence and digital watermarks, which are technologies that OPTEL has been developing and perfecting for decades.
The webinar will include a question and answer period, during which participants will have an opportunity to interact with the three webinar speakers to question or clarify any of the issues surrounding the EU FMD.
For more information or to register for this event, visit One Year After EU FMD Compliance: What Issues Need to be Addressed?
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.